CRMD
Price
$5.86
Change
-$0.24 (-3.93%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
397.61M
34 days until earnings call
PXXLF
Price
$0.25
Change
-$0.45 (-64.29%)
Updated
Nov 25 closing price
Capitalization
14.22M
Ad is loading...

CRMD vs PXXLF

Header iconCRMD vs PXXLF Comparison
Open Charts CRMD vs PXXLFBanner chart's image
CorMedix
Price$5.86
Change-$0.24 (-3.93%)
Volume$16.93K
Capitalization397.61M
Poxel SA
Price$0.25
Change-$0.45 (-64.29%)
Volume$750
Capitalization14.22M
CRMD vs PXXLF Comparison Chart
Loading...
CRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRMD vs. PXXLF commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRMD is a Hold and PXXLF is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 05, 2025
Stock price -- (CRMD: $6.10 vs. PXXLF: $0.25)
Brand notoriety: CRMD and PXXLF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRMD: 70% vs. PXXLF: 100%
Market capitalization -- CRMD: $397.61M vs. PXXLF: $14.22M
CRMD [@Biotechnology] is valued at $397.61M. PXXLF’s [@Biotechnology] market capitalization is $14.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRMD’s FA Score shows that 0 FA rating(s) are green whilePXXLF’s FA Score has 1 green FA rating(s).

  • CRMD’s FA Score: 0 green, 5 red.
  • PXXLF’s FA Score: 1 green, 4 red.
According to our system of comparison, PXXLF is a better buy in the long-term than CRMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRMD’s TA Score shows that 4 TA indicator(s) are bullish.

  • CRMD’s TA Score: 4 bullish, 6 bearish.

Price Growth

CRMD (@Biotechnology) experienced а -9.09% price change this week, while PXXLF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.29%. For the same industry, the average monthly price growth was -17.13%, and the average quarterly price growth was -18.92%.

Reported Earning Dates

CRMD is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-11.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRMD($398M) has a higher market cap than PXXLF($14.2M). PXXLF YTD gains are higher at: 0.000 vs. CRMD (-24.691).
CRMDPXXLFCRMD / PXXLF
Capitalization398M14.2M2,803%
EBITDA-47.32MN/A-
Gain YTD-24.6910.000-
P/E RatioN/AN/A-
Revenue12.3MN/A-
Total Cash46MN/A-
Total Debt556KN/A-
FUNDAMENTALS RATINGS
CRMD vs PXXLF: Fundamental Ratings
CRMD
PXXLF
OUTLOOK RATING
1..100
5133
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
92
Overvalued
PROFIT vs RISK RATING
1..100
95100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
6583
P/E GROWTH RATING
1..100
1001
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRMD's Valuation (55) in the Medical Specialties industry is somewhat better than the same rating for PXXLF (92) in the null industry. This means that CRMD’s stock grew somewhat faster than PXXLF’s over the last 12 months.

CRMD's Profit vs Risk Rating (95) in the Medical Specialties industry is in the same range as PXXLF (100) in the null industry. This means that CRMD’s stock grew similarly to PXXLF’s over the last 12 months.

CRMD's SMR Rating (98) in the Medical Specialties industry is in the same range as PXXLF (100) in the null industry. This means that CRMD’s stock grew similarly to PXXLF’s over the last 12 months.

CRMD's Price Growth Rating (65) in the Medical Specialties industry is in the same range as PXXLF (83) in the null industry. This means that CRMD’s stock grew similarly to PXXLF’s over the last 12 months.

PXXLF's P/E Growth Rating (1) in the null industry is significantly better than the same rating for CRMD (100) in the Medical Specialties industry. This means that PXXLF’s stock grew significantly faster than CRMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRMD
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
72%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 26 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Ad is loading...
CRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
AWEG22.38N/A
N/A
Alger Weatherbie Enduring Growth ETF
VAMO28.95-0.54
-1.82%
Cambria Value and Momentum ETF
GRID111.26-3.77
-3.28%
First Trust NASDAQ® Cln Edge®StGidIfsETF
AUSF42.48-1.44
-3.28%
Global X Adaptive US Factor ETF
WTAI18.08-1.41
-7.26%
WisdomTree Artfcl Intllgnc & Innvtn ETF

CRMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRMD has been loosely correlated with MURA. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CRMD jumps, then MURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRMD
1D Price
Change %
CRMD100%
-3.17%
MURA - CRMD
49%
Loosely correlated
-6.82%
ARTL - CRMD
33%
Poorly correlated
-3.01%
HOTH - CRMD
32%
Poorly correlated
-4.65%
RLYB - CRMD
32%
Poorly correlated
-3.97%
XLO - CRMD
31%
Poorly correlated
-4.24%
More

PXXLF and

Correlation & Price change

A.I.dvisor indicates that over the last year, PXXLF has been loosely correlated with RLYB. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if PXXLF jumps, then RLYB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PXXLF
1D Price
Change %
PXXLF100%
N/A
RLYB - PXXLF
44%
Loosely correlated
-3.97%
VERU - PXXLF
37%
Loosely correlated
-8.41%
SEOVF - PXXLF
28%
Poorly correlated
+7.50%
BRTX - PXXLF
25%
Poorly correlated
-2.70%
CRMD - PXXLF
24%
Poorly correlated
-3.17%
More